Total Payments
$2,409
2024 Payments
$65.64
Companies
27
Transactions
121
Medicare Patients
525
Medicare Billing
$338,534
Payment Breakdown by Category
Food & Beverage$2,400 (99.6%)
Education$8.80 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,400 | 119 | 99.6% |
| Education | $8.80 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Daiichi Sankyo Inc. | $454.97 | 29 | $0 (2019) |
| Allergan, Inc. | $279.37 | 17 | $0 (2021) |
| Amgen Inc. | $170.46 | 3 | $0 (2018) |
| Merz North America, Inc. | $162.97 | 5 | $0 (2019) |
| ABBVIE INC. | $121.31 | 7 | $0 (2024) |
| Avanir Pharmaceuticals, Inc. | $121.13 | 7 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $97.97 | 5 | $0 (2019) |
| Abbott Laboratories | $94.10 | 2 | $0 (2019) |
| US WorldMeds, LLC | $93.73 | 5 | $0 (2020) |
| Purdue Pharma L.P. | $93.04 | 6 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $65.64 | 4 | ABBVIE INC. ($65.64) |
| 2022 | $96.55 | 5 | DePuy Synthes Sales Inc. ($56.51) |
| 2021 | $62.89 | 3 | Allergan, Inc. ($47.26) |
| 2020 | $117.39 | 7 | Allergan, Inc. ($61.26) |
| 2019 | $521.42 | 24 | Merz North America, Inc. ($125.83) |
| 2018 | $499.89 | 25 | Daiichi Sankyo Inc. ($140.52) |
| 2017 | $1,045 | 53 | Daiichi Sankyo Inc. ($293.15) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/16/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/10/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 05/08/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/29/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Sports Early Intervention | ||||||
| 04/26/2022 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Sports Early Intervention | ||||||
| 04/26/2022 | DePuy Synthes Sales Inc. | ORTHOVISC (Device) | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Sports Early Intervention | ||||||
| 09/22/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: NEUROSCIENCE | ||||||
| 06/23/2021 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: HYPERHYDROSIS | ||||||
| 02/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Neuroscience | ||||||
| 10/14/2020 | US WorldMeds, LLC | MYOBLOC (Biological) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Neurology | ||||||
| 09/23/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/22/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2020 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Neuroscience | ||||||
| 02/19/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: HYPERHYDROSIS | ||||||
| 01/28/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2019 | Merz North America, Inc. | — | Food and Beverage | Cash or cash equivalent | $104.46 | General |
| 11/19/2019 | GENZYME CORPORATION | POMPE - DISEASE (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| 11/15/2019 | Abbott Laboratories | Infinity DBS Pulse Generators (Device) | Food and Beverage | In-kind items and services | $37.14 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/15/2019 | Zyla Life Sciences | SPRIX (Drug) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Pain Medicine | ||||||
| 11/13/2019 | Avanir Pharmaceuticals, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: pseudobulbar affect (PBA) | ||||||
| 10/31/2019 | Allergan Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.26 | General |
| Category: HYPERHYDROSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 84 | 14,041 | $224,855 | $87,003 |
| 2022 | 7 | 96 | 5,863 | $158,565 | $44,378 |
| 2021 | 8 | 147 | 13,866 | $337,300 | $86,897 |
| 2020 | 10 | 198 | 18,370 | $174,973 | $120,256 |
Total Patients
525
Total Services
52,140
Medicare Billing
$338,534
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 14 | 13,600 | $115,600 | $67,603 | 58.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 55 | $15,025 | $6,346 | 42.2% |
| 64616 | Injection of chemical for paralysis of nerve muscles on side of neck excluding voice box | Office | 2023 | 14 | 31 | $44,800 | $5,655 | 12.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 59 | $30,375 | $4,156 | 13.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 39 | $8,775 | $3,026 | 34.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 15 | 257 | $10,280 | $215.30 | 2.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 12 | 5,561 | $94,890 | $27,222 | 28.7% |
| J7324 | Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | Office | 2022 | 11 | 68 | $31,120 | $7,928 | 25.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 14 | 61 | $15,900 | $4,350 | 27.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 36 | $9,010 | $2,785 | 30.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 11 | 18 | $6,105 | $2,006 | 32.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 15 | 97 | $1,430 | $87.37 | 6.1% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2022 | 11 | 22 | $110.00 | $0.44 | 0.4% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 20 | 13,500 | $270,000 | $65,368 | 24.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 90 | $23,400 | $7,574 | 32.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 21 | 45 | $17,100 | $5,457 | 31.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 14 | 60 | $13,200 | $4,694 | 35.6% |
| 64616 | Injection of chemical for destruction of nerve muscles on one side of neck excluding voice box accessed through the skin | Office | 2021 | 16 | 25 | $13,000 | $3,751 | 28.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 16 | 50 | $250.00 | $49.16 | 19.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 11 | 20 | $100.00 | $2.49 | 2.5% |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | Office | 2021 | 22 | 76 | $250.26 | $1.24 | 0.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2020 | 29 | 18,002 | $123,010 | $87,182 | 70.9% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2020 | 19 | 29 | $8,545 | $6,491 | 76.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 75 | $11,517 | $5,889 | 51.1% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2020 | 17 | 54 | $8,136 | $5,595 | 68.8% |
About Dr. Julia Altmann, M.D
Dr. Julia Altmann, M.D is a Physical Medicine & Rehabilitation healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/24/2008. The National Provider Identifier (NPI) number assigned to this provider is 1043471808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julia Altmann, M.D has received a total of $2,409 in payments from pharmaceutical and medical device companies, with $65.64 received in 2024. These payments were reported across 121 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($2,400).
As a Medicare-enrolled provider, Altmann has provided services to 525 Medicare beneficiaries, totaling 52,140 services with total Medicare billing of $338,534. Data is available for 4 years (2020–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Interventional Pain Medicine, Physical Medicine & Rehabilitation
- Location New York, NY
- Active Since 06/24/2008
- Last Updated 11/19/2019
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1043471808
Products in Payments
- Movantik (Drug) $332.28
- BOTOX (Biological) $212.94
- Aimovig (Biological) $124.67
- Morphabond ER (Drug) $122.69
- AIMOVIG (Biological) $97.97
- NUEDEXTA (Drug) $91.54
- UBRELVY (Drug) $87.26
- Cambia (Drug) $86.86
- APOKYN (Drug) $58.79
- Xtampza ER (Drug) $58.26
- Deep Brain Stimulation (Device) $56.96
- ORTHOVISC (Device) $56.51
- METHYLPHENIDATE 72 (Drug) $47.34
- SYMPROIC (Drug) $46.27
- Supartz (Device) $44.52
- MIGRANAL (Drug) $42.38
- LYRICA (Drug) $42.03
- Amitiza (Drug) $40.34
- EMGALITY (Drug) $39.28
- SPRIX (Drug) $38.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in New York
Heidi Fusco, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $160,307
Physical Medicine & Rehabilitation $160,307
Dr. Kimberly Sackheim, Do, DO
Physical Medicine & Rehabilitation — Payments: $158,974
Physical Medicine & Rehabilitation $158,974
Michael O'dell, Md, MD
Physical Medicine & Rehabilitation — Payments: $103,549
Physical Medicine & Rehabilitation $103,549
Dr. Craig Antell, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $78,788
Physical Medicine & Rehabilitation $78,788
Russell Silver, Md, MD
Physical Medicine & Rehabilitation — Payments: $66,937
Physical Medicine & Rehabilitation $66,937
Ehsan Abdeshahian, Md, MD
Physical Medicine & Rehabilitation — Payments: $54,837
Physical Medicine & Rehabilitation $54,837